Johnson & Johnson profit rises 4 percent on pharma sales

[July 14, 2015]  (Reuters) - Johnson & Johnson reported a 4 percent rise in quarterly profit as sales of its mainstay older drugs managed to offset the impact of a strong dollar on overseas revenue.

The company's net profit rose to $4.52 billion, or $1.61 per share, in the second quarter, from $4.33 billion, or $1.51 per share, a year earlier.

Excluding special items, the company earned $1.71 per share.

Revenue fell nearly 9 percent to $17.79 billion.

Sales of its medical devices fell 12.2 percent to $6.36 billion.

(Reporting by Vidya L Nathan in Bengaluru; Editing by Sriraj Kalluvila)

[© 2015 Thomson Reuters. All rights reserved.]

Copyright 2015 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.